The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

Marijke Coomans*, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin van den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstrom, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Martin J. B. TaphoornEORTC Quality Life Grp, EORTC Brain Tumor Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)190-198
Number of pages9
JournalEuropean Journal of Cancer
Volume116
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Glioma
  • Health-related quality of life (HRQoL)
  • Prognostic factor
  • Brain tumour
  • Survival
  • PHASE-III
  • PREDICTING SURVIVAL
  • CANCER-PATIENTS
  • COGNITIVE FUNCTION
  • CLINICAL-TRIALS
  • BRAIN-TUMOR
  • EORTC
  • GLIOBLASTOMA
  • VALIDATION
  • SYMPTOMS

Cite this